Avantor, Inc. (NYSE:AVTR) Shares Sold by Swedbank AB

Swedbank AB decreased its stake in Avantor, Inc. (NYSE:AVTR) by 10.6% during the 4th quarter, Holdings Channel reports. The firm owned 93,887 shares of the company’s stock after selling 11,111 shares during the quarter. Swedbank AB’s holdings in Avantor were worth $1,978,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Hantz Financial Services Inc. grew its stake in Avantor by 2.1% during the 3rd quarter. Hantz Financial Services Inc. now owns 24,900 shares of the company’s stock valued at $644,000 after acquiring an additional 503 shares in the last quarter. Blue Trust Inc. boosted its holdings in shares of Avantor by 6.9% during the 4th quarter. Blue Trust Inc. now owns 8,069 shares of the company’s stock worth $170,000 after purchasing an additional 522 shares during the last quarter. Pacer Advisors Inc. grew its position in shares of Avantor by 0.5% in the fourth quarter. Pacer Advisors Inc. now owns 99,825 shares of the company’s stock valued at $2,103,000 after purchasing an additional 542 shares in the last quarter. Veracity Capital LLC increased its holdings in shares of Avantor by 1.0% in the third quarter. Veracity Capital LLC now owns 52,359 shares of the company’s stock valued at $1,355,000 after purchasing an additional 543 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB lifted its position in Avantor by 99.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after buying an additional 625 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Price Performance

Shares of AVTR opened at $22.26 on Monday. The firm has a market capitalization of $15.15 billion, a PE ratio of 48.38, a P/E/G ratio of 3.82 and a beta of 1.28. The stock’s 50 day moving average is $21.69 and its two-hundred day moving average is $23.45. Avantor, Inc. has a twelve month low of $19.59 and a twelve month high of $28.00. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on AVTR. Barclays dropped their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Friday, October 25th. Raymond James cut their price target on shares of Avantor from $29.00 to $26.00 and set an “outperform” rating for the company in a report on Tuesday, January 21st. Wells Fargo & Company decreased their price objective on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Robert W. Baird cut their target price on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Finally, UBS Group restated a “neutral” rating and issued a $25.00 target price (down previously from $29.00) on shares of Avantor in a research report on Friday, January 17th. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $27.38.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.